Evaluation of the Efficacy of Biobran (Rice Bran Arabinoxylan) in Supporting Breast Cancer Chemotherapy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age20-65
SponsorChina Medical University Hospital
About this trial
This study aims to evaluate the potential supportive effects of rice bran arabinoxylan compound (Biobran) in patients with breast cancer receiving paclitaxel and doxorubicin chemotherapy. The study will assess chemotherapy-related side effects, quality of life, tumor size, tumor antigens, and routine blood test parameters over 24 weeks of treatment.
Eligibility criteria
Qualifiers
Breast cancer stage I-III
Disqualifiers
pregnant, lactation, breast recurrence, mental disease, autoimmune disease over hte past 5 years, people who take plant or fungal polysaccharide health supplements
Trial design
Treatments tested in this trial
- Biobran supplementation
Treatment groups
96 Participants
are divided into 2 treatment groupsLocations
2China Medical University406040, Taichung Taiwan
China Medical University Hospital406040, Taichung Taiwan
Sponsors and collaborators
China Medical University Hospital
Lead sponsor
Source ClinicalTrials.gov